Drug-induced valvular heart disease: An update

被引：33
|
作者：
Andrejak, Michel [1 ,2 ]
Tribouilloy, Christophe [2 ,3 ]
机构：
[1] CHU Amiens, Hop Sud, Serv Pharmacol Clin, F-80054 Amiens 1, France
[2] INSERM, U1088, Amiens, France
[3] CHU Amiens, Serv Cardiol, Amiens, France
来源：
ARCHIVES OF CARDIOVASCULAR DISEASES | 2013年 / 106卷 / 05期
关键词：
Drug induced valvular disease; Ergot alkaloids; Ergot-derived dopamine agonists; Norfenfluramine; Valvular regurgitation; APPETITE-SUPPRESSANT DRUGS; CARDIAC-VALVE REGURGITATION; PARKINSONS-DISEASE; BENFLUOREX THERAPY; DOPAMINE AGONISTS; TRICUSPID REGURGITATION; METHYSERGIDE THERAPY; INDUCED VALVULOPATHY; DIABETES-MELLITUS; FENFLURAMINE;
D O I：
10.1016/j.acvd.2013.02.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Numerous reports have shown an unquestionable association between fibrotic valve disease and the following drugs: ergot alkaloids (such as methysergide and ergotamine), ergot-derived dopaminergic agonists (such as pergolide and cabergoline) and drugs metabolized into norfenfluramine (such as fenfluramine, dexfenfluramine and benfluorex). This review focuses on different aspects of drug-induced valvular heart disease: historical background; echocardiographic features; different drugs recognized as being responsible for valvular heart disease; and pathophysiology. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：333 / 339
页数：7
相关论文
共 50 条
  • [1] Drug-induced valvular heart disease
    Blaschke, D.
    Rolf, S.
    Parwani, A. S.
    Huemer, M.
    Dietz, R.
    Garbe, E.
    Haverkamp, W.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 (08) : 365 - 370
  • [2] Drug-induced valvular heart disease
    Cosyns, Bernard
    Droogmans, Steven
    Rosenhek, Raphael
    Lancellotti, Patrizio
    HEART, 2013, 99 (01) : 7 - 12
  • [3] Drug-induced fibrotic valvular heart disease
    Bhattacharyya, Sanjeev
    Schapira, Anthony H.
    Mikhailidis, Dimitri P.
    Davar, Joseph
    LANCET, 2009, 374 (9689): : 577 - 585
  • [4] Benfluorex: the last chapter of drug-induced valvular heart disease?
    Droogmans, Steven
    Cosyns, Bernard
    Van Camp, Guy
    EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2011, 12 (04): : 263 - 264
  • [5] In vivo model of drug-induced valvular heart disease in rats:: pergolide-induced valvular heart disease demonstrated with echocardiography and correlation with pathology
    Droogmans, Steven
    Franken, Philippe R.
    Garbar, Christian
    Weytjens, Caroline
    Cosyns, Bernard
    Lahoutte, Tony
    Caveliers, Vicky
    Pipeleers-Marichal, Miriam
    Bossuyt, Axel
    Schoors, Danny
    Van Camp, Guy
    EUROPEAN HEART JOURNAL, 2007, 28 (17) : 2156 - 2162
  • [6] Role of Serotoninergic Pathways in Drug-Induced Valvular Heart Disease and Diagnostic Features by Echocardiography
    Smith, Sakima A.
    Waggoner, Alan D.
    de las Fuentes, Lisa
    Davila-Roman, Victor G.
    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2009, 22 (08) : 883 - 889
  • [7] DRUG-INDUCED PULMONARY-DISEASE - AN UPDATE
    ROSENOW, EC
    MYERS, JL
    SWENSEN, SJ
    PISANI, RJ
    CHEST, 1992, 102 (01) : 239 - 250
  • [8] DRUG-INDUCED PULMONARY-DISEASE - AN UPDATE
    ARONCHICK, JM
    GEFTER, WB
    JOURNAL OF THORACIC IMAGING, 1991, 6 (01) : 19 - 29
  • [9] Update on Valvular Heart Disease
    Haettasch, Robert
    Dorta, Elena Romero
    Knebel, Fabian
    AKTUELLE KARDIOLOGIE, 2020, 9 (01) : 66 - 75
  • [10] Caseous necrosis of the mitral annulus: a new feature of drug-induced valvular heart disease? Case series
    Leblon, Tiphaine
    Riolet, Clemence
    Ennezat, PierreVladimir
    Marechaux, Sylvestre
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2022, 6 (01)
12345